Item 8.01 Other Events.

In connection with the acquisition of certain needle incineration technology formerly known as The Disintegrator ("SANDD™"), on or about December 31, 2015, the Registrant entered into a consulting agreement ("Agreement") with the owner of SANDD™.

In exchange for advisory services to be provided to the Registrant by the consultant ("Consultant"), the Registrant agreed to issue up to 60,000,000 shares of its common stock to the Consultant. Under the terms of the Agreement, the common stock is to be issued in three (3) separate tranches of 20,000,000 million shares each after the Registrant reached three (3) separate mutually agreed upon performance milestones.

During the fiscal year ended June 30, 2020, the Registrant issued 20,000,000 shares of common stock to the Consultant under the terms of the Agreement after the Registrant had reached the first mutually agreed upon milestone. The Registrant has not yet reached the second and third mutually agreed upon milestones under the terms of the Agreement, as such, 40,000,000 shares remain unissued.

On October 18, 2021, the Registrant entered into a Separation Agreement with the Consultant to cancel all of the remaining obligations under the Agreement effective October 31, 2021, with the cash payment of $75,000 by the Registrant from available working capital, on or before October 31, 2021, and an additional cash payment of $50,000 from available working capital, on or before November 30, 2021.

© Edgar Online, source Glimpses